Lecithin cholesterol acyltransferase deficiency

Revision as of 16:49, 9 August 2012 by WikiBot (talk | contribs) (Robot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search


Lecithin cholesterol acyltransferase deficiency
ICD-10 E78.6
OMIM 245900 136120
DiseasesDB 7343
eMedicine med/1270 

Lecithin cholesterol acyltransferase deficiency (LCAT deficiency) is a disorder of lipoprotein metabolism. Lecithin cholesterol acyltransferase catalyzes the formation of cholesterol esters in lipoproteins. The disease has two forms: familial LCAT deficiency in which there is complete LCAT deficiency and fish eye disease inwhich there is a partial deficiency. Both are autosomal recessive disorders caused by mutations of the LCAT gene located on chromosome 16q22. A deficiency of LCAT causes accumulation of unesterified cholesterol in certain body tissues. Symptoms of the familial form include diffuse corneal opacities, target cell hemolytic anemia and proteinuria with renal failure. Fish eye disease only causes progressive corneal opacification.

References

  • Kuivenhoven J, Pritchard H, Hill J, Frohlich J, Assmann G, Kastelein J (1997). "The molecular pathology of lecithin:cholesterol acyltransferase (LCAT) deficiency syndromes". J Lipid Res. 38 (2): 191–205. PMID 9162740.

Template:Endocrine, nutritional and metabolic pathology

Template:WikiDoc Sources